The 1st year of the COVID-19 epidemic in Estonia: a population-based nationwide sequential/consecutive cross-sectional study
- PMID: 35287021
- PMCID: PMC8825347
- DOI: 10.1016/j.puhe.2022.02.004
The 1st year of the COVID-19 epidemic in Estonia: a population-based nationwide sequential/consecutive cross-sectional study
Abstract
Objectives: The objective of this study was to assess the population prevalence of SARS-CoV-2 and changes in the prevalence in the adult general population in Estonia during the 1st year of COVID-19 epidemic.
Study design: This was a population-based nationwide sequential/consecutive cross-sectional study.
Methods: Using standardised methodology (population-based, random stratified sampling), 11 cross-sectional studies were conducted from April 2020 to February 2021. Data from nasopharyngeal testing and questionnaires were used to estimate the SARS-CoV-2 RNA prevalence and factors associated with test positivity.
Results: Between April 23, 2020, and February 2, 2021, results were available from 34,915 individuals and 27,870 samples from 11 consecutive studies. The percentage of people testing positive for SARS-CoV-2 decreased from 0.27% (95% confidence interval [CI] = 0.10%-0.59%) in April to 0.04% (95% CI = 0.00%-0.22%) by the end of May and remained very low (0.01%, 95% CI = 0.00%-0.17%) until the end of August, followed by an increase since November (0.37%, 95% CI = 0.18%-0.68%) that escalated to 2.69% (95% CI = 2.08%-2.69%) in January 2021. In addition to substantial change in time, an increasing number of household members (for one additional odds ratio [OR] = 1.15, 95% CI = 1.02-1.29), reporting current symptoms of COVID-19 (OR = 2.21, 95% CI = 1.59-3.09) and completing questionnaire in the Russian language (OR 1.85, 95% CI 1.15-2.99) were associated with increased odds for SARS-CoV-2 RNA positivity.
Conclusions: SARS-CoV-2 population prevalence needs to be carefully monitored as vaccine programmes are rolled out to inform containment decisions.
Keywords: COVID-19; Epidemiology; Estonia; Health inequalities; Prevalence; SARS-CoV-2; Surveillance.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Figures


References
-
- WHO WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11. March 2020. https://www.who.int/dg/speeches/detail/
-
- COVID-19 situation update worldwide, as of week 49. 2021. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases Updated 16 December 2021.
-
- Koroonakaart. [Coronamap] 2022. https://koroonakaart.ee/en
-
- Statistics Estonia Population indicators and composition. 2021. https://andmed.stat.ee/en/stat
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous